Advertising

Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Become a member Or, Sign In
Latest Top Picks

Stock Opinions by Samuel D. Isaly

TOP PICK
Growing very well. Their biggest drug is for high blood pressure but also have a good product line for cancer treatment. Not many patent exposures in the near-term.
biotechnology / pharmaceutical
TOP PICK
Lots of new products. Rapid profit growth.
biotechnology / pharmaceutical
TOP PICK
A very rapidly growing company. Earnings per share growth is in excess of 20% yearly. PE ratio barely more than that.
biotechnology / pharmaceutical
TOP PICK
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
biotechnology / pharmaceutical
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »